CID 3058017

((dihydroxy-3,4 phenyl)-2 hydroxy-2) ethyl-1 (oxo-2 benzimidazolinyl-1)-4 piperidine [french]

Structural Information

Molecular Formula
C20H23N3O4
SMILES
C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC(C4=CC(=C(C=C4)O)O)O
InChI
InChI=1S/C20H23N3O4/c24-17-6-5-13(11-18(17)25)19(26)12-22-9-7-14(8-10-22)23-16-4-2-1-3-15(16)21-20(23)27/h1-6,11,14,19,24-26H,7-10,12H2,(H,21,27)
InChIKey
SXWTWEOHZMNYIE-UHFFFAOYSA-N
Compound name
3-[1-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]piperidin-4-yl]-1H-benzimidazol-2-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

369.16885 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 370.17613 188.5
[M+Na]+ 392.15807 201.0
[M+NH4]+ 387.20267 193.6
[M+K]+ 408.13201 197.5
[M-H]- 368.16157 190.7
[M+Na-2H]- 390.14352 193.2
[M]+ 369.16830 190.6
[M]- 369.16940 190.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.